The University of Texas MD Anderson Cancer Center
Overview
The University of Texas MD Anderson Cancer Center is a comprehensive cancer research and treatment institution that operates as a strategic investor in biotechnology companies and collaborates with investment funds like the Cancer Focus Fund to advance oncology therapies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| March Biosciences | Oct 2024 | Series A | - |
| KAHR Medical | Jun 2021 | VC Round | - |
| Eisbach Bio GmbH | Mar 2024 | VC Round | - |
| Nectin Therapeutics | Nov 2022 | Grant | - |
| Starget Pharma | Feb 2026 | Series A | - |
For institutional investors. Book with your work email.
Key People
Tanya Gibbons
Managing Director
Cassian Yee
T Cells in Space a CASIS NASA funded oroject to study effects of microgravity on T cell fate, Professor, Melanoma Medical Oncology, Professor, Department of Immunology, Director, Solid Tumor Cell Therapy
Chachere R
Principal Project Manager
EDAC Erica Parker
Innovation Principal
Edith Nagy
Principal Scientist
Natenael Semmineh
Principal Research Scientist
Otto Akers
Principal Safety Specialist
Sreedhar Mandayam
Professor, Principal Investigator
Tony Benedetto
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The University of Texas MD Anderson Cancer Center based?
The University of Texas MD Anderson Cancer Center is headquartered in Houston, Texas, United States.
When was The University of Texas MD Anderson Cancer Center founded?
The University of Texas MD Anderson Cancer Center was founded in 1941.
How many portfolio companies does The University of Texas MD Anderson Cancer Center have?
The University of Texas MD Anderson Cancer Center has 10 portfolio companies in Caplight's dataset.
What are some companies in The University of Texas MD Anderson Cancer Center's portfolio?
Portfolio companies visible on Caplight include March Biosciences, KAHR Medical, Eisbach Bio GmbH, Nectin Therapeutics, Starget Pharma.
What was The University of Texas MD Anderson Cancer Center's most recent investment shown here?
The University of Texas MD Anderson Cancer Center's most recent investment in this portfolio sample was in Starget Pharma in 2026.
What sectors does The University of Texas MD Anderson Cancer Center focus on?
The University of Texas MD Anderson Cancer Center focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does The University of Texas MD Anderson Cancer Center focus on?
The University of Texas MD Anderson Cancer Center typically invests at the MultiStage stage.
What is The University of Texas MD Anderson Cancer Center's AUM?
The University of Texas MD Anderson Cancer Center's assets under management are estimated between $50.0M and $300.0M.